Google DeepMind and Isomorphic Labs have unveiled AlphaFold 3, a groundbreaking AI model poised to rewrite the rulebook on molecular biology and redefine t...
The National Institute of Nutrition (NIN), under the Indian Council of Medical Research (ICMR), has released updated "Dietary Guide...
Industry pioneers Maria Batalha, Kevin J. Bittorf, Matthew Mollan, and John Nadzam took center stage at INTERPHEX 2024 to share their expertise and insight...
Conference Session Recap: Leveraging AI for Fraud Detection in Pharma - Insights from INTERPHEX 2024 Attendees at INTERPHEX 2024 were treated to a t...
Today, attendees at INTERPHEX 2024 were treated to an illuminating presentation by Metin Celiak, delving into the transformative potential of Artificial In...
Paragonix Technologies, Inc., a pioneer in organ transplant technologies and services, announces the annual release of the latest GUARDIAN-Heart Clinical R...
The trials demonstrated V116's effectiveness in generating immune responses across all 21 serotypes covered by the vaccine in diverse adult...
In an effort to bridge testing gaps and facilitate targeted therapies for EOC patients, Labcorp conducted two seminal studies, illustrating the profound im...
New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis Late-breaking dat...
One of the notable achievements in fiscal 2023 was Catalent's robust efforts to mitigate its environmental impact and combat climate ...
Rob Truckenmiller, Senior Vice President, Head of US Vaccines, GSK, emphasized the importance of collaborative efforts and fi...
23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, released three new genetic reports for 23andMe+ members on breast...
In a landmark move within the life sciences sector, Novo Holdings has announced its acquisition of Catalent, Inc. in an all-cash transaction valued at $16....
Biopharma M&A in 2023 Biopharma M&A activity has witnessed a decisive rebound in 2023, with aggregate deal value up by 79% vs. 2022 to reach ~$152...
© 2024 Biopharma Boardroom. All Rights Reserved.
